RU  UA  EN

Monday, 25 November

00:10
Pfizer summed up the results of vaccination for six months
The Pfizer/BioNTech COVID-19 vaccine was able to prove its effectiveness within six months vaccinating period.

13:50
AstraZeneca has given its coronavirus vaccine a new name — Vaxzevria
The Swedish-British company AstraZeneca has changed the name of its coronavirus vaccine to Vaxzevria.

12:29
The first batch of the Chinese coronavirus vaccine was exported to Ukraine
The first batch of the Chinese coronavirus vaccine CoronaVac has been prepared for shipment to Ukraine.

23:21
India to delay big exports of the CovidShield vaccine as infections surge
India has put a temporary hold on all major exports of the CovidShield (AstraZeneca) coronavirus vaccine developed by the Serum Institute of India (SII), the world’s biggest vaccine-maker, to meet domestic demand as infections rise, Reuters reports.

07:12
Pfizer initiates phase 1 study of the novel oral antiviral therapeutic drug against COVID-19
The American company Pfizer Inc, which has created a vaccine against COVID-19, announced that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the safety and tolerability of an investigational, novel oral antiviral therapeutic for SARS-CoV-2, the virus that causes COVID-19.

22:39
A Belgian university has discovered a new coronavirus variant
A new mutation of the coronavirus (Covid-19) has been detected in Belgium by the university in Liège (ULiège) and currently accounts for about 4% of infections in the country, as was reported by Le Figaro.

06:48
"There's pressure": the EU stated when it shall share COVID-19 vaccines with poorer countries
Despite earlier promises, EU Chief Ursula von der Leyen has said the bloc cannot donate COVID-19 vaccines to developing countries while it struggles with its own supply, the Deutshe Welle reports.

18:24
European Medicines Agency Europe has made an important statement about the safety of the AstraZeneca vaccine
European Medicines Agency’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of March 18, 2021.

10:32
EU countries suspend the use of the AstraZeneca vaccine
Increasingly more countries suspend the use of the AstraZeneca coronavirus vaccine due to the reports of side effects in the form of blood clots.

15:47
AstraZeneca finds no evidence of increased blood clot risks from vaccine
AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots, as was reported by Reuters.

17:29
COVID-19 vaccine Janssen is now authorised across the EU
European Medicines Agency has recommended granting a conditional marketing authorisation for COVID-19 vaccine Janssen from Johnson&Hohnson to prevent COVID-19 in people from 18 years of age.

13:30
Denmark has suspended the use of AstraZeneca vaccine as a 'precautionary measure'
Denmark is suspending the use of the Oxford-AstraZeneca vaccine for two weeks as it investigates reports of some patients developing blood clots after being inoculated, days after several other EU countries suspended the use of a specific batch of the vaccine.

15:29
The EU plans impose the COVID-19 certificates in May: the Czech Republic issued a loud statement
The introduction of digital vaccination passports, which was agreed upon during the virtual EU Summit, may take place in May this year.

19:14
EU regulator urges caution on Sputnik COVID-19 vaccine
A senior European Medicines Agency (EMA) official urged European Union members on Sunday to refrain from granting national approvals for Russian COVID-19 vaccine Sputnik V while the agency reviews its safety and effectiveness.

12:55
President Zelensky was vaccinated against COVID-19 in the Donbas
During a working trip to the Luhansk region, President of Ukraine Volodymyr Zelensky was vaccinated against COVID-19, as was reported by the press-service of the Office of the President of Ukraine.

10:08
The US authorizes J&J's COVID-19 vaccine, making it the third one available
On Saturday, February 27, the U.S. government authorized Johnson & Johnson’s single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.

06:54
The European Union is going to introduce digital vaccination passports
Digital vaccination certificates enabling people to travel in Europe despite the coronavirus pandemic will likely be available before summer, German Chancellor Angela Merkel said after a virtual EU summit, as was reported by Reuters.

13:19
Ukraine starts vaccination against COVID-19
On Wednesday, February 24, Ukraine started a vaccination campaign against COVID-19. The first vaccines were directed to the regions at 7 a.m.

18:34
COVID-19: Europe is preparing for the increased threat of variants
On Wednesday, February 17, the European Commission has proposed immediate action to prepare Europe for the increased threat of coronavirus variants – the new European bio-defence preparedness plan against COVID-19 variants called “HERA Incubator”, as was reported by the press service of the European Commission.

22:18
Seven dangerous coronavirus strains were found in the US
Seven coronavirus mutations have been detected in the U.S., which may be more dangerous than the common strain of COVID-19, as was reported by the Medrxiv portal.